Search Results
Salesforce Doubles Million Dollar Impact on Cancer
They say, “Teamwork makes the dream work” and the 2016 Light The Night Salesforce team’s March to a Million initiative has proved this is true. As LLS’s longtime Light The Night partner, the team of more than 1,880 participants from across the U.S. went above and beyond this year to fight blood cancer. Not only did they meet their $1 million dollar fundraising goal, but Salesforce has generously offered to match it— bringing their total amount raised to more than $2 million for LLS’s goal to create a world without blood cancers!
Choosing a Blood Cancer Specialist
Hematologists specialize in internal medicine with a subspecialty in hematology, the study of diseases of the blood. A “hematologist-oncologist” is a doctor who specializes in treating people with blood cancers. Pediatric hematologist-oncologists treat infants, children, and adolescents with blood cancers. Blood cancers are uncommon diseases, so it can be to your advantage to be treated by a doctor specially trained to focus on treating patients with blood cancers.
Understanding Blood Cancers and Treatment Options
Leukemia, lymphoma, myeloma, myelodysplastic syndromes (MDSs) and myeloproliferative neoplasms (MPNs) are types of cancer that can affect the bone marrow, blood cells, lymph nodes and other parts of the lymphatic system. See the Disease Information pages to learn more about the different types of blood cancer.
Blood Cancer and Treatment Options
Treatment OptionsAfter your child is diagnosed with a blood cancer, you will work with members of the healthcare team to determine the best treatment plan. Treatment options vary depending on the patient's diagnosis, age, overall health, and other factors. Your child’s treatment plan might include
On World Cancer Day: LLS Honors International Researchers
World Cancer Day is February 4, when people across the globe come together to work toward reducing the global burden of cancer. An integral part of this work is scientific research that leads to innovative treatments, ultimately saving lives.
Despite promising advances in treatment, cancers are among the leading cause of disease and deaths worldwide. Cancers know no boundaries, and have devastating impacts on families across the globe.
The Cost of Cancer Care and its Impact on Patients
LLS is on the frontlines of the battle against blood cancers, and we are alarmed by the stories that patients and their families are sharing with us about their struggles to access affordable, high-quality and stable care. Last year, our free Information Resource Center received more than 26,000 calls from patients and families – the majority included concerns about financial stress and difficulties accessing treatment.
Walgreens helps raise more than $6 million for The Leukemia & Lymphoma Society (LLS) and Susan G. Komen to Advance Cancer Research and Increase Access to Care
Join us in thanking Walgreens stores and customers across the country for raising over $6 million for LLS and Susan G. Komen during their spring campaign. Donations made at checkout at more than 9,000 U.S. Walgreens locations will be split evenly between the two organizations.
During this multi-year partnership, Walgreens has helped to donate more than $25 million by 2024 to advance research for tough-to-treat cancers and increase equitable access to care.
Advances in Cancer Research and Treatment in 2020
Progress in new cancer treatments is accelerating so rapidly that the standard of care for many cancer patients is changing right before our very eyes.
Since 2017, the U.S. Food and Drug Administration (FDA) has approved a remarkable 53 therapies just to treat patients with blood cancers, and The Leukemia & Lymphoma Society (LLS) has helped advance 46 of these treatments.
I have no reason to believe the next few years won’t be as productive and groundbreaking as the last few. With that, here are some of my predictions for 2020:
A Cancer Survivor Gives Back
When I meet newly diagnosed cancer patients and their caregivers, a familiar look greets me. I have seen this look countless times. In waiting rooms, during a weekly support lunch for patients and caregivers, and on my own mother’s face.
It is a look of fear, confusion and doubt. It is a look that expresses the need for survival at all costs, yet without any assurance of success. It is a look that I can still see when I look in the mirror.
That look is often replaced almost immediately after I say: “Hi, my name is Ron. I am a leukemia and stem-cell transplant survivor.”
A Special Delivery for Mom with Cancer
On April 8, 2016, I was diagnosed with acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia (AML). I was 23 weeks pregnant. For almost five years, my husband, Allan, and I battled unexplained infertility. After three failed fertility treatments, we finally found ourselves pregnant the “au natural” way!
Honoring a Devoted UFCW “Cancer Kicker”
Frank Meehan spent two decades spearheading the United Food & Commercial Workers’ (UFCW) effort to raise money to defeat blood cancers. As president of the Long Island, NY Local, he was one of the first leaders to act upon the union’s national relationship with The Leukemia & Lymphoma Society (LLS).
Then last spring, in a twist of fate, he ended up losing his life to one of the aggressive leukemias he’d been hoping to see cured.
LLS Scholarship for Blood Cancer Survivors
The Leukemia & Lymphoma Society (LLS) knows how challenging it can be to plan for your future during or after cancer treatment. Hospital stays and interruptions in school may mean pausing your goals. And the high cost of cancer care can make affording higher education difficult.
Cancer and Sun Safety: What You Need to Know
Summer is in full swing, and many of us are enjoying outdoor activities and lots of time in the sun. For cancer patients, being mindful of sun exposure before, during and after cancer treatment is extremely important.
According to The Leukemia & Lymphoma Society’s (LLS) Information Specialists, a team of master’s level oncology social workers, nurses and health educators, sunlight has benefits, but it is important to protect yourself from too much sun exposure.
Meet the Researcher: Omar Abdel-Wahab, MD
This is part of a periodic series of Q&A’s with LLS-funded researchers. Dr. Abdel-Wahab of Memorial Sloan Kettering Cancer Center focuses on an area of research called epigenetics – chemical modifications that regulate (switch on and off) gene activity. He is studying how these processes drive the development of acute myeloid leukemia and other blood cancers. He currently holds a Career Development Program grant from LLS, a program that supports scientists earlier in their careers.
Q. What is the focus of your research and its primary goal?
Attention Hockey Fans: LLS and The National Hockey League Fight Cancer Together
LLS is teaming up with the National Hockey League (NHL®) and the National Hockey League Players’ Association’s (NHLPA) joint initiative, Hockey Fights Cancer™ annual campaign. This is LLS’s seventh season participating in HFC. The 18th annual Hockey Fights Cancer campaign kicks off on October 24 and runs until November 18.
Remembering Cancer with a Tattoo, New Career and Anniversary Party
In Jon Christoffersen’s house, important occasions - such as the end of chemotherapy - are worthy of great celebration. First it was a tattoo to mark the beginning and end of his treatment, and now, on his 10-year anniversary of being cancer free, it’s time to party.
High School Student Proves Youngest Generation Can Make an Impact on Cancer Research and Cures
Ella Behnke of San Antonio, Texas, is a 16-year-old cheerleader who attends Alamo Heights High School and is making history, as the winner of The Leukemia & Lymphoma Society’s (LLS) national title “Student of the Year.” Ella raised more than $334,768 for LLS to invest in cancer cures with an intense seven-week fundraising campaign involving everything from a very active campaign team, social media activations to visiting cancer patients at the Children’s Hospital of San Antonio.
Walgreens, The Leukemia & Lymphoma Society and Susan G. Komen Collaborating to Support Research in Tough-to-Treat Cancers and Increase Access to Care
In February, Walgreens launched their annual spring fundraiser for The Leukemia & Lymphoma Society and Susan G. Komen to enable research in tough-to-treat cancers and increase access to care with a pledge to contribute more than $25 million to the organizations, collectively, through 2024. Through a combination of online and in-store donations, the commitment enables research in metastatic breast and pediatric blood cancers, as well as increases access, treatment and support services for those living with these diseases.